Medpace

Medpace is a full-service contract research organization that provides comprehensive clinical development services. The company specializes in accelerating the advancement of medical therapeutics through integrated clinical trial management, spanning study start-up, monitoring, data management, and biostatistics. It operates with a therapeutically-focused model, incorporating both central and bioanalytical laboratory services to support global clinical programs efficiently.

The organization was founded in July 1992 by Dr. August J. Troendle. Prior to establishing Medpace, Dr. Troendle gained experience managing clinical development at Sandoz, now Novartis. His founding insight stemmed from a belief that a specialized contract research partner could dramatically enhance the efficiency and overall quality of the drug development pathway for new therapies.

Medpace primarily serves biotech and pharmaceutical sponsors seeking to bring novel medical therapeutics to market. Its core mission is to accelerate the development of safe and effective treatments through continuous advancements in clinical research. The company strives to provide a unified, accountable, and streamlined platform that ultimately improves the speed and integrity of clinical trials.